Vimarsana
Biggest News Aggregation in the World

Page 37 - Cm Management News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cm Management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cm Management Today - Breaking & Trending Today

AMCON Distributing (NYSEAMERICAN:DIT) Sees Significant Increase in Short Interest - Vimarsana News

AMCON Distributing (NYSEAMERICAN:DIT) Sees Significant Increase in Short Interest

AMCON Distributing (NYSEAMERICAN:DIT – Get Rating) saw a large growth in short interest in May. As of May 15th, there was short interest totalling 300 shares, a growth of 50.0% from the April 30th total of 200 shares. Approximately 0.2% of the shares of the stock are sold short. Based on an average daily trading […]

Thomas A. Satterfield, Jr. Purchases 128,496 Shares of RealNetworks, Inc. (NASDAQ:RNWK) Stock - Vimarsana News

Thomas A. Satterfield, Jr. Purchases 128,496 Shares of RealNetworks, Inc. (NASDAQ:RNWK) Stock

RealNetworks, Inc. (NASDAQ:RNWK – Get Rating) major shareholder Thomas A. Satterfield, Jr. purchased 128,496 shares of the company’s stock in a transaction dated Thursday, May 26th. The stock was bought at an average price of $0.63 per share, with a total value of $80,952.48. Following the completion of the transaction, the insider now directly owns […]

Gain Therapeutics (NASDAQ:GANX) Upgraded at Zacks Investment Research - Vimarsana News

Gain Therapeutics (NASDAQ:GANX) Upgraded at Zacks Investment Research

Gain Therapeutics (NASDAQ:GANX – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Wednesday, Zacks.com reports. The firm presently has a $2.75 target price on the stock. Zacks Investment Research‘s price target indicates a potential upside of 3.77% from the stock’s previous […]

Angion Biomedica Corp. (NASDAQ:ANGN) Sees Large Growth in Short Interest - Vimarsana News

Angion Biomedica Corp. (NASDAQ:ANGN) Sees Large Growth in Short Interest

Angion Biomedica Corp. (NASDAQ:ANGN – Get Rating) was the recipient of a significant growth in short interest in the month of April. As of April 30th, there was short interest totalling 649,500 shares, a growth of 20.1% from the April 15th total of 540,800 shares. Approximately 3.5% of the company’s shares are sold short. Based […]

Eledon Pharmaceuticals (NASDAQ:ELDN) Coverage Initiated by Analysts at Cantor Fitzgerald - Vimarsana News

Eledon Pharmaceuticals (NASDAQ:ELDN) Coverage Initiated by Analysts at Cantor Fitzgerald

Analysts at Cantor Fitzgerald initiated coverage on shares of Eledon Pharmaceuticals (NASDAQ:ELDN – Get Rating) in a research report issued on Friday, FinViz reports. The firm set an “overweight” rating and a $15.00 price target on the stock. ELDN has been the topic of several other reports. HC Wainwright reaffirmed a “buy” rating and issued […]